Genistein

製品コードS1342

Genistein化学構造

分子量(MW):270.24

Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.

サイズ 価格(税別)  
JPY 14940.00
JPY 11620.00
JPY 18260.00
JPY 28220.00

文献中Selleckの製品使用例(1)

製品安全説明書

EGFR阻害剤の選択性比較

生物活性

製品説明 Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.
ターゲット
EGFR [1] topo II [1]
体外試験

Genistein is an ATP competitive inhibitor. Genistein inhibits tyrosine phosphorylation in isolated enzyme and receptor preparations and in whole cells including platelets, lymphocytes and a variety of cultured cells. It also inhibits EGF-stimulated phosphorylation in cultured cells as well as inhibition of Topo II (topoisomerase II). Genistein inhibits EGF-stimulated tyrosine phosphorylation in cultured A431 epidermoid carcinoma cells. Inhibition is competitive with ATP and noncompetitive with substrate. [1] Genistein blocks the mitogenic effect mediated by EGF, insulin and thrombin on NIH-3T3 cells.[2] Genistein also acts as an agonist at the GPR30 receptor and binds to PPARγ and estrogen receptors. Genistein also binds to PPARγ, acting as an agonist at this receptor with Ki of 5.7 μM. [3]

細胞データ
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
293T cells MX3GeY5kfGmxbjDhd5NigQ>? MXTEbZNxdGGlZX3lcpQhd2ZiW{PIYVE4[mW2YT3ld5Rz[WSrb3yg[pJwdSC{ZXPvcYJqdmGwdDDoeY1idiCHUnLleIEh\XiycnXzd4VlKGmwIEK5N3Qh[2WubIOsJGlEPTB;MD6wNFE{KM7:TR?= NF\CTpEyPjJzOUS2Ny=>
HeLa cells M1i0e2Z2dmO2aX;uJIF{e2G7 MnPuRYN1cX[jdHnvckBw\iCnc4Tyc4dmdiC{ZYPwc45{\SCnbHXt[Y51KGmwIFjlUIEh[2WubIOgd5Ri[my7IITyZY5{\mWldHXkJJdqfGhiaIXtZY4hTXO2cn;n[Y4hemWlZYD0c5Ih[mW2YTygSWM2OD1yLkCwOFEh|ryP MXKxNVkxPjJ6MB?=
human Ishikawa cells MU\GeY5kfGmxbjDhd5NigQ>? NWLpbGd5PCCmYYnz NVv4T2dqTXO2cn;n[Y5q[yCjY4Tpeol1gSCrbjDoeY1idiCLc3jpb4F4[SClZXzsd{Bie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gZYxs[WyrbnWgdIhwe3CqYYThd4Uh[WO2aY\peJkh[W[2ZYKgOEBl[Xm|IHL5JJBiemFvbnn0do9xcGWwb3ygdoVt\WG|ZTDhd5NigSxiSVO1NF0xNjVzIN88US=> NHK0ZlUyOjVyMkOwOy=>
human MCF7 cells NXHRflJKS3m2b4TvfIlkyqCjc4PhfS=> MWe0PEBp NWXwOZNiS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUOINzDj[YxteyCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCLQ{WwQVEh|ryP MlHVNlA5OTN3MkS=
NIH3T3 cells MVzGeY5kfGmxbjDhd5NigQ>? NGXzclhC\2:waYP0JIFkfGm4aYT5JIF1KEOIVGKt[IVtfGGINUC4JI12fGGwdDDlfJBz\XO|ZXSgbY4hVkmKM2SzJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKG[xcoPrc4xqdi2|dHnteYxifGWmIHP1dpJmdnRuIFXDOVA:PC52IN88US=> Mn[zNVg2QTV4OU[=
human HL60 cells NYXMSYJZTnWwY4Tpc44h[XO|YYm= NF3nXmYzPCCq NGLHUWdCdnSrbHX1b4VucWNiYXP0bZZqfHliYXfhbY5{fCCqdX3hckBJVDZyIHPlcIx{KGGodHXyJFI1KGi{czDifUBkdG:wb3flcolkKGG|c3H5MEBNSzVyPU[uN{DPxE1? M2C1SFE5OTZ|NUi5
mouse L1210 cells NFjGSGxHfW6ldHnvckBie3OjeR?= NVLObZVROjRiaB?= M2P5[mFvfGmuZYXr[Y1q[yCjY4Tpeol1gSCjZ3HpcpN1KG2xdYPlJGwyOjFyIHPlcIx{KGGodHXyJFI1KGi{czDifUBkdG:wb3flcolkKGG|c3H5MEBNSzVyPU[uOUDPxE1? MkL2NVgyPjN3OEm=
MDCK cells  NV\ORVV5TnWwY4Tpc44h[XO|YYm= NHrPRVBKdmirYnn0bY9vKG:oIFLDVnAh\XiycnXzd4VlKGmwIF3ER2sh[2WubIOgeZNqdmdiSH;lZ4h{fCB|M{O0NkB{fGGrbnnu[{whUUN3ME22Mlkh|ryP Mn24NlE{PTR6MEC=
human MOLT3 cells NYXxc|FwTnWwY4Tpc44h[XO|YYm= M2j0XFI1KGh? MVzBcpRqdGW3a3XtbYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNU2xVOyClZXzsd{Bi\nSncjCyOEBpenNiYomgZ4xwdm:pZX7pZ{Bie3OjeTygUGM2OD15LkWg{txO NUW0NHBROThzNkO1PFk>
ANN-1 cells Ml;KR5l1d3SxeHnjxsBie3OjeR?= MkjVR5l1d3SxeHnjJIVn\mWldDDvckB3NWGkbDD0doFve2[xcn3l[EBufXKrbnWgRW5PNTFiY3XscJMtKEmFNUC9PEDPxE1? MUK4NlAyPjB|
human MCF7 cells MmDJVJJwdGmoZYLheIlwdiCjc4PhfS=> NYnYTJBlSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBme3S{b3flckBz\WOncITvdkBmgHC{ZYPzbY5oKGi3bXHuJG1ETjdiY3XscJMtKEeLNUC9NVAh|ryP M4nv[FE6QDF6NkGy
human Raji cells NEmxdZRHfW6ldHnvckBie3OjeR?= MVqyOEBp Mki3RY51cWyndXvlcYlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVoFrcSClZXzsd{Bi\nSncjCyOEBpenNiYomgZ4xwdm:pZX7pZ{Bie3OjeTygUGM2OD1zMz63JO69VQ>? MVGxPFE3OzV6OR?=
human LoVo cells NF3GWYVEgXSxdH;4bYPDqGG|c3H5 NH7ZNHM4OiCq NHr4cnBEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBNd1[xIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9NVUvQDhizszN NHPjRWgzOTF{OUm3Oy=>
K562 cells MnTTS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M1jxOFUh\GG7cx?= NIXyOZRIem:5dHigbY5pcWKrdHnvckBw\iCNNU[yJINmdGy|IHL5JHhVXCCjc4PhfUBi\nSncjC1JIRigXNuIFnDOVA:OTdwNU[g{txO NInwVnUyPzRzMUC5Ni=>
RAW 264 cells NI\lbHZHfW6ldHnvckBie3OjeR?= MmrXNlQhcA>? MYjJcohq[mm2aX;uJI9nKDFidXevcYwhVFCVLYP0bY12dGG2ZXSgWG5H[WyyaHGgZYNkfW23bHH0bY9vKGmwIGLBW{AzPjRiY3XscJMh[W[2ZYKgNlQhcHK|LDDJR|UxRTF6LkGg{txO Ml3nNVc{OjB{NE[=
mouse RAW264.7 cells NIf6[FZHfW6ldHnvckBie3OjeR?= M1K0bVI1KGh? NFvsOItCdnSraX7mcIFudWG2b4L5JIFkfGm4aYT5JIlvKG2xdYPlJHJCXzJ4ND63JINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiTGDTMYlv\HWlZXSgWG5H[WyyaHGgdJJw\HWldHnvckB1emWjdHXkJFIhcHK|IHLl[o9z\SCOUGOgZ4hidGynbnflJI1m[XO3cnXkJIFnfGW{IEK0JIhzeyCkeTDFUGlUSSxiSVO1NF0yQS5zIN88US=> NHfPZnczOTJ6OEeyOy=>
HEK293 cells NVf6VplYTnWwY4Tpc44h[XO|YYm= NIPmc2pCdnSjZ3;ubZN1KGGldHn2bZR6KGG2IHj1cYFvKHKnY3;tZolv[W62IFzYVoJmfGFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEmFNUC9NlIh|ryP M1rJTVE5OzR|MUK2
3T3 cells M1foeWN6fG:2b4jpZ:Kh[XO|YYm= NX\WeG9PS3m2b4TvfIlkKGWoZnXjeEBwdiB|VEOgZ4VtdHNuIFnDOVA:OjRizszN MnrtPFIxOTZyMx?=
human MCF7 cells NYDH[HZ4TnWwY4Tpc44h[XO|YYm= NIe1eo83KGh? MnHZTY5pcWKrdHnvckBw\iCyaH;yZo9tKGW|dHXyMYlv\HWlZXSgc5JvcXSqaX7lJIRm[2G{Yn;4fYxie2ViaX6gbJVu[W5iTVPGO{Bk\WyuczDh[pRmeiB4IHjyd{whUUN3ME2yOkDPxE1? MYexNFA4PTd2Mh?=
WiDr human colon cells NF\rN3dEgXSxdH;4bYPDqGG|c3H5 NWXMZ|FsS3m2b4TvfIlkKGWoZnXjeEBwdiCZaVTyJIh2dWGwIHPvcI9vKGOnbHzzMEBKSzVyPUK3Mlch|ryP MoGyPFIxOTZyMx?=
NHEM cells NHX3bndHfW6ldHnvckBie3OjeR?= MXO3NkBp M3;wOGlvcGmkaYTpc44hd2ZibXXsZY5qdiC|eX70bIV{cXNiaX6gUmhGVSClZXzsd{Bie3Onc4Pl[EBieyCdMUTDYZRpcW:3cnHjbYwhcW6lb4Lwc5JifGmxbjDh[pRmeiB5MjDodpMh[nlibHnxeYllKHOlaX70bYxt[XSrb36gZ492dnSrbnesJGlEPTB;MkmuNkDPxE1? NG\vSVkyQTF|MkmzOC=>
human BxPC3 cell M3HFcnBzd2yrZnXyZZRqd25iYYPzZZk> M{jUU2FvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQojQR|Mh[2WubDDsbY5mKGK7IF3UWEBie3OjeTygTWM2OD1|MDFOwG0> NYS0bXNvOTZ5OEm3N|c>
human LNCAP cells NUjxXGh5S3m2b4TvfIlkyqCjc4PhfS=> NUTyV2RtPzJiaB?= M1f1dGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGxPS0GSIHPlcIx{KGGodHXyJFczKGi{czDifUBUWkJiYYPzZZktKEmFNUC9N|AvPjVizszN MWOyNVEzQTl5Nx?=
HEK293 cells NUHrVYQ4TnWwY4Tpc44h[XO|YYm= MXjBcpRi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJJJm[2:vYnnuZY51KEy[UnHsdIhiKGW6cILld5Nm\CCrbjDISWszQTNiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyPUOxJO69VQ>? MnXZNVg{PDNzMk[=
human HCT116 cells MlXhR5l1d3SxeHnjxsBie3OjeR?= MWO3NkBp NILYfXhEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJS1RzMU[gZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiSVO1NF0{PC57IN88US=> Mof6NlEyOjl7N{e=
human AGS cells M{DCdmN6fG:2b4jpZ:Kh[XO|YYm= M{W5NFczKGh? NWPJNGIzS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSUeVIHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9OFEvPjdizszN Mn3wNlEyOjl7N{e=
human PC3 cells M3ezT3Bzd2yrZnXyZZRqd25iYYPzZZk> NXm0d5JCPDhiaB?= Mnz3RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDhcoRzd2enbjDy[YNmeHSxcj3k[YZq[2mnboSgbJVu[W5iUFOzJINmdGy|IHnuZ5Vj[XSnZDD3bZRpKDBwNjDuUUBw\iCnc4TyZYRqd2xiYX7kJFAvPyCwTTDv[kB1\XO2b4P0[ZJwdmViYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;NEKuOlU5KM7:TR?= NUnhZm9sOjF3MUOyO|U>
human A549 cells MY\DfZRwfG:6aXRCpIF{e2G7 M1\0ZlczKGh? NVGwUI5LS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTV2OTDj[YxteyCjZoTldkA4OiCqcoOgZpkhW1KEIHHzd4F6NCCLQ{WwQVQ{NjB7IN88US=> M3nrNFIyOTJ7OUe3
human BT20 cell M{DuXXBzd2yrZnXyZZRqd25iYYPzZZk> MlLyRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCEVEKwJINmdGxibHnu[UBjgSCPVGSgZZN{[XluIFnDOVA:PDZizszN M33XRlE3Pzh7N{O3
human DU145 cells MnLpR5l1d3SxeHnjxsBie3OjeR?= M3jHdVczKGh? M37rdGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGRWOTR3IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUC9OFcvOjlizszN NGnLd3UzOTF{OUm3Oy=>
human U937 cells MX\Qdo9tcW[ncnH0bY9vKGG|c3H5 MVy3NkBp M1TMXGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVUmzO{Bk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUMVgh[XO|YYmsJGlEPTB;NEig{txO NIjub5MyPzF3OEC1OC=>
human MOLT3 cells NIP0eYdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NHvyUGc1QCCq NWj0b4xET3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hVU:OVEOgZ4VtdHNiYX\0[ZIhPDhiaILz NH3mdVQyQDF4M{W4PS=>
human T47D cells NVexeIZ3TnWwY4Tpc44h[XO|YYm= M1nCU2V{fHKxZ3XubYMh[WO2aY\peJkhcW5iaIXtZY4hXDR5RDDj[YxteyCjc4Pld5Nm\CCjczDkdpVoKGyndnXsJINifXOrbnegd5RqdXWuYYTpc44hd2ZiY3XscEBxem:uaX\ldoF1cW:wIHXxeYl3[WynboSgeI8hOTBicF2g[ZN1emGmaX;sJIJ6KGGuYX3hdkBjdHWnIHHzd4F6 MXGxOVc5PzR|Nh?=
human MDA-kb2 cells MlPOSpVv[3Srb36gZZN{[Xl? M3XiXGFod26rc4SgZYN1cX[rdImgZZQh[W6mcn;n[Y4hemWlZYD0c5IhcW5iaIXtZY4hVUSDLXviNkBk\WyuczDhd5Nme3OnZDDhd{B{fGmvdXzheIlwdiCxZjDseYNq\mW{YYPlJIFkfGm4aYT5JIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeR?= MmHPNVk2QTJ{NEW=
human MCF7 cells MnW1SpVv[3Srb36gZZN{[Xl? NGnrNGwxNjFvMkCg{txO NGrocYc1KGSjeYO= NVLWcIIyW3SrbYXsZZRqd25ib3[g[5Jwf3SqIHnuJIh2dWGwIF3DSlch[2WubIOgZZQhOC5zIITvJFIxKHWPIHHmeIVzKDRiZHH5d{BjgSCPVGSgZZN{[Xl? MXiyOVA4QDNzNB?=
HUVE12 cells MYnGeY5kfGmxbjDhd5NigQ>? M1G4bHJmfmW{c3HsJI9nKGi7ZILv[4VvKHCncn;4bYRmNWmwZIXj[YQhVESKIHHjeIl3cXS7IHnuJIh2dWGwIFjVWmUyOiClZXzsdy=> NIjCfVEyQDB4OEm4NC=>
human MCF7 cells M1zweWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NEXlU28zOC1zMECg{txO MnXwOEBl[Xm| NEXUPFFIem:5dHigbY5pcWKrdHnvckBqdiCqdX3hckBOS0Z5IHPlcIx{KGG2IEKwJJRwKDFyMDD1UUBi\nSncjC0JIRigXNiYomgUXRVKGG|c3H5 M{\oXFI2ODd6M{G0
A431 cells NIPUXW9HfW6ldHnvckBie3OjeR?= MXi1NEB1dyB5NTD1US=> MlvuN|YhcA>? NVfad2pCS2WubDDjfYNt\SCjcoLld5QhcW5iaIXtZY4hSTR|MTDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBi[2O3bYXsZZRqd25iYYSgS|AwTzFicHjhd4Uh[XRiNUCgeI8hPzVidV2gZYZ1\XJiM{[gbJJ{KGK7IIDyc5Bq\Gm3bTDpc4Rq\GVic4ThbY5qdmdvYnHz[YQh\myxdzDjfZRwdWW2cnnjJIFv[Wy7c3nz MmDENlQ1PTZyMES=
human SKBR3 cells NHXUSmJHfW6ldHnvckBie3OjeR?= NHv1XFg2OCC2bzC3OUB2VQ>? NWLxc2RnOzZiaB?= NGnHW5hE\WyuIHP5Z4xmKGG{cnXzeEBqdiCqdX3hckBUU0KUMzDj[YxteyCjc4Pld5Nm\CCjczDk[YNz\WG|ZTDpckBi[2O3bYXsZZRqd25iYYSgS|AwTzFicHjhd4Uh[XRiNUCgeI8hPzVidV2gZYZ1\XJiM{[gbJJ{KGK7IIDyc5Bq\Gm3bTDpc4Rq\GVic4ThbY5qdmdvYnHz[YQh\myxdzDjfZRwdWW2cnnjJIFv[Wy7c3nz NXjSUpdROjR2NU[wNFQ>

他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

体内試験 Genistein has chemopreventive effects on breast, prostate, and other endocrine-dependent tumors in adult animals. Genistein in the diet reduced the incidence of poorly differentiated prostatic adenocarcinomas in a dose-dependent manner and down-regulated androgen receptor, estrogen receptor-alpha, progesterone receptor, epidermal growth factor receptor, insulin-like growth factor-I, and extracellular signal-regulated kinase-1 but not estrogen receptor-beta and transforming growth factor-alpha mRNA expressions. Dietary genistein protects against mammary and prostate cancers by regulating specific sex steroid receptors and growth factor signaling pathways.[4] Genistein combined with prostate tumor irradiation causes greater inhibition of primary tumor growth and increases control of spontaneous metastasis to para-aortic lymph nodes, increasing mouse survival. Paradoxically, treatment with genistein alone increases metastasis to lymph nodes. [5]

お薦めの試験操作(参考用のみ)

溶解度 (25°C)

体外 DMSO 54 mg/mL (199.82 mM)
Ethanol 2 mg/mL (7.4 mM)
Water Insoluble

* 溶解度測定はSelleck技術部門によって行われており、その他文献に示されている溶解度と差異がある可能性がありますが、同一ロットの生産工程で起きる正常な現象ですからご安心ください。

化学情報

分子量 270.24
化学式

C15H10O5

CAS No. 446-72-0
保管
in solvent
別名 N/A

便利ツール

モル濃度計算器

モル濃度計算器

求めたい質量、体積または濃度を計算してください。

質量 (g) = 濃度 (mol/L) x 体積 (L) x 分子量 (g/mol)

モル濃度計算器方程式

  • 質量
    濃度
    体積
    分子量

*貯蔵液を準備するとき、常に、オンであるとわかる製品のバッチに特有の分子量を使って、を通してラベルとMSDS/COA(製品ページで利用可能な)。

希釈計算器

希釈計算器

貯蔵液を準備するために必要な希釈率を計算してください。Selleck希釈計算器は、以下の方程式に基づきます:

開始濃度 x 開始体積 = 最終濃度 x 最終体積

希釈の計算式

この方程式は、一般に略語を使われます:C1V1 = C2V2 ( 入力 出力 )

  • C1
    V1
    C2
    V2

常に貯蔵液を準備するとき、小びんラベルとMSDS/COA(オンラインで利用できる)で見つかる製品のバッチに特有の分子量を使ってください。

連続希釈計算器方程式

  • 連続希釈剤

  • 計算結果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量計算器

分子量计算器

そのモル質量と元素組成を計算するために、合成物の化学式を入力してください:

総分子量:g/mol

チップス: 化学式は大文字と小文字の区別ができます。C10H16N2O2 c10h16n2o2

モル濃度計算器

質量 濃度 体積 分子量

臨床試験

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02766478 Recruiting Prostate Cancer Emory University October 16 2017 Phase 2
NCT01489813 Recruiting Bladder Cancer Emory University|DSM Nutritional Products Inc. May 19 2017 Phase 2
NCT03040531 Recruiting Osteoporosis Steroid Induced University of Messina|Ministry of Health Italy January 19 2017 Phase 2|Phase 3
NCT02624388 Recruiting Lymphoma|Childhood Lymphoma|Solid Tumor|Childhood Solid Tumor|Neuroblastoma|Ewing Sarcoma|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|Rhabdomyosarcoma|Soft Tissue Sarcoma|Medulloblastoma|Germ Cell Tumor|Wilms Tumor|Brain Neoplasms|Medulloblastoma Childhood|Neuroectodermal Tumors Primitive University of Virginia August 2016 Phase 2
NCT02499861 Completed Cancer St. Justine''s Hospital July 2015 Phase 1|Phase 2
NCT02796794 Unknown status Sepsis TC Erciyes University June 2015 Phase 4

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

  • * 必須

EGFRシグナル伝達経路

相関EGFR製品

Tags: Genisteinを買う | Genistein ic50 | Genistein供給者 | Genisteinを購入する | Genistein費用 | Genistein生産者 | オーダーGenistein | Genistein化学構造 | Genistein分子量 | Genistein代理店
×
細胞株 試験類型 濃度 培養時間 溶剤類型 活性叙述 PMID